CO-INHIBITORY RECEPTORS IN NON-UROTHELIAL BLADDER CANCER-TARGETS FOR NEXT GENERATION IMMUNOTHERAPY

被引：0
|
作者：
Eismann, Lennert
Ledderose, Stephan
Marcon, Julian
Bischoff, Robert
Waidelich, Raphaela
Schulz, Gerald
Casuscelli, Jozefina
Stief, Christian
Rodler, Severin
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-04
引用
收藏
页码：E1078 / E1078
页数：1
相关论文
共 50 条
  • [21] Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
    Flammia, Rocco Simone
    Chierigo, Francesco
    Wuernschimmel, Christoph
    Wenzel, Mike
    Horlemann, Benedikt
    Tian, Zhen
    Borghesi, Marco
    Leonardo, Costantino
    Tilki, Derya
    Shariat, Shahrokh F.
    Anceschi, Umberto
    Chun, Felix K. H.
    Terrone, Carlo
    Saad, Fred
    Gallucci, Michele
    Karakiewicz, Pierre I.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (03) : 240 - 247
  • [22] Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities
    Deuker, Marina
    Martin, Thomas
    Stolzenbach, Franziska
    Rosiello, Giuseppe
    Ruvolo, Claudia Colla
    Nocera, Luigi
    Tian, Zhe
    Becker, Andreas
    Kluth, Luis
    Roos, Frederik C.
    Tilki, Derya
    Shariat, Shahrokh F.
    Black, Peter C.
    Kassouf, Wassim
    Saad, Fred
    Chun, Felix
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2021, 19 (01) : 60 - +
  • [23] Chemotherapy with significant mortality benefit in patients with bladder cancer with variant and non-urothelial histologies (NUVH).
    Perimbeti, Stuthi
    Jiang, Changchuan
    Deng, Lei
    Roy, Arya Mariam
    Gupta, Shilpi
    Kambam, Greeshma
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] COMPETING MORTALITY IN BLADDER CANCER PATIENTS AFTER CYSTECTOMY: THE ROLE OF SECOND NON-UROTHELIAL CANCERS
    Hensley, Patrick
    Duan, Zhigang
    Bree, Kelly
    Sood, Akshay
    Kokorovic, Andrea
    Zhao, Hui
    Guo, Charles
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2021, 206 : E909 - E909
  • [25] Effects of treatment and patterns of metastases in upper tract and bladder urothelial cancer and non-urothelial cancer based on the national cancer database (NCDB) analysis
    Yu, Eun-mi
    Wang, Hongkun
    Aragon-Ching, Jeanny B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Toll-like receptors in urothelial cells-targets for cancer immunotherapy
    LaRue, Helene
    Ayari, Cherifa
    Bergeron, Alain
    Fradet, Yves
    NATURE REVIEWS UROLOGY, 2013, 10 (09) : 537 - 545
  • [27] Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder
    Erdem, Gokmen U.
    Dogan, Mutlu
    Sakin, Abdullah
    Oruc, Zeynep
    Yaman, Emel
    Cinkir, Havva Yesil
    Uysal, Mukremin
    Bozkurt, Oktay
    Ozturk, Banu
    Aytekin, Aydin
    Ozcelik, Melike
    Bahceci, Aykut
    Cakiroglu, Umut
    Turhal, Serdar
    Sahin, Suleyman
    Uncu, Dogan
    Zengin, Nurullah
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (04) : 220 - 225
  • [28] Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy
    Kean, Leslie S.
    Turka, Laurence A.
    Blazar, Bruce R.
    IMMUNOLOGICAL REVIEWS, 2017, 276 (01) : 192 - 212
  • [29] THE POTENTIAL IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR NON-UROTHELIAL MUSCLE INVASIVE BLADDER CANCER
    Gelpi-Hammerschmidt, Francisco
    Rodriguez, Dayron
    Tinay, Ilker
    Allard, Christopher
    Hanna, Nawar
    Chang, Steven
    Trinh, Quoc-Dien
    Preston, Mark
    JOURNAL OF UROLOGY, 2016, 195 (04): : E8 - E8
  • [30] Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)
    Geng, Qiaohong
    Rohondia, Sagar O.
    Khan, Harras J.
    Jiao, Peifu
    Dou, Q. Ping
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (09) : 677 - 694
12345